Rapid Test for MRSA and MRCoNS receives FDA Approval
Thermo Scientific PBP2' Test identifies MRSA and MRCoNS
The Thermo Scientific PBP2' Test has received FDA approval for the identification of MRSA and MRCoNS, making this the first rapid latex test to be approved for the confirmation of resistance in both Staphylococcus aureus and coagulase negative staphylococci.
On evaluating the Thermo Scientific PBP2' test in the United States, Mary York, a highly respected opinion leader in the field of antimicrobial susceptibility testing, commented, "I'm very excited about this new method. I would see Thermo Scientific PBP2' being used either as a confirmatory test or a rapid test to get the patient on the right antibiotics."
Thermo Scientific PBP2' conforms to the NCCLS guidelines for the detection of oxacillin resistance (M100-S12).
Source: Thermo Scientific. View latest company information
Posted: April 30, 2002
[will open your email client]